Selective activation of the fatty acid synthesis pathway in human prostate cancer
Open Access
- 13 September 2000
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 88 (2) , 176-179
- https://doi.org/10.1002/1097-0215(20001015)88:2<176::aid-ijc5>3.0.co;2-3
Abstract
A substantial subset of breast, colorectal, ovarian, endometrial and prostatic cancers displays markedly elevated expression of immunohistochemically detectable fatty acid synthase, a feature that has been associated with poor prognosis and that may be exploited in anti‐neoplastic therapy. Here, using an RNA array hybridisation technique complemented by in situ hybridisation, we report that in prostate cancer fatty acid synthase expression is up‐regulated at the mRNA level together with other enzymes of the same metabolic pathway. Contrary to the observations that in many cell systems (including androgen‐stimulated LNCaP prostate cancer cells) fatty acid and cholesterol metabolism are co‐ordinately regulated so as to supply balanced amounts of lipids for membrane biosynthesis, storage or secretion, no changes in the expression of genes involved in cholesterol synthesis were found. These findings point to selective activation of the fatty acid synthesis pathway and suggest a shift in the balance of lipogenic gene expression in a subgroup of prostate cancers. Int. J. Cancer 88:176–179, 2000.Keywords
This publication has 17 references indexed in Scilit:
- Differential Stimulation of Cholesterol and Unsaturated Fatty Acid Biosynthesis in Cells Expressing Individual Nuclear Sterol Regulatory Element-binding ProteinsPublished by Elsevier ,1998
- "Spot 14" Protein: A Metabolic Integrator in Normal and Neoplastic CellsThyroid®, 1998
- Fatty acid synthase expression in endometrial carcinomaCancer, 1998
- ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism.Genes & Development, 1996
- Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patientsCancer, 1996
- Sterol Regulation of Fatty Acid Synthase PromoterJournal of Biological Chemistry, 1995
- The prognostic value of oncogenic antigen 519 (OA‐519) expression and proliferative activity detected by antibody MIB‐I in node‐negative breast cancerThe Journal of Pathology, 1995
- OA-519 (fatty acid synthase) as an independent predictor of pathologic stage in adenocarcinoma of the prostateUrology, 1995
- Fatty acid synthesis: a potential selective target for antineoplastic therapy.Proceedings of the National Academy of Sciences, 1994
- Beta‐microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinomaThe Prostate, 1993